Riskpilot← Back to searchSign inGet full accessMedtech innovation i Umeå AB
ABActiveOrg 5590114756Hissjövägen 40Engineering activities and related technical consultancy · NACE 7112Est. 20150 employees
Revenue 2024
SEK 0
EBITDA margin
—
+42% vs 2023
Equity ratio
34.9%
Financial strength
Net profit 2024
SEK -1K
+94% vs 2023
| Revenue | SEK 0 | — |
| EBITDA | SEK -19K | +42% |
| Net profit | SEK -1K | +94% |
| Total assets | SEK 1M | -7% |
| Equity | SEK 358K | -6% |
| Employees | 0 | — |
Legal name
Medtech innovation i Umeå AB
Org number
5590114756
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
22 april 2015
Share capital
SEK 50 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva produktionsutveckling av medicinsk teknik mot mikrodialyskatetrar, konsultera inom området mikrodialys, förvaltande av värdepapper samt därmed förenlig verksamhet.
Address
Hissjövägen 40
Email
pernillaabrahamsson1972@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −22 | −25 | −24 | −33 | −19 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −22 | −25 | −24 | −33 | −19 |
| Net financials | 1 130 | 130 | 442 | 7 | 24 |
| Profit before tax | 830 | 77 | 312 | −17 | 5 |
| Tax | −178 | −17 | −65 | −0 | −6 |
| Net profit | 652 | 60 | 247 | −17 | −1 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 601 | 1 289 | 1 153 | 1 107 | 1 027 |
| Equity | 719 | 529 | 397 | 379 | 358 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 347 | 198 | 88 | 68 | 9 |
| Total debt | 347 | 198 | 88 | 68 | 9 |
EBITDA margin
-1900000.0%
This company
15.8%
Market median
-12025416% vs market
20202024
Equity ratio
34.9%
This company
38.2%
Market median
+9% vs market
20202024
Return on equity
-0.3%
This company
18.4%
Market median
-102% vs market
20202024
Net profit margin
-100000.0%
This company
8.1%
Market median
-1234668% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medtech innovation i Umeå AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Birgitta Pernilla Abrahamsson | Board of Directors | 0 companies |
| Olof Mattias Abrahamsson | Deputy Board Member | 0 companies |